Authors: Sharon Salt, Editor
At the Alzheimer’s Association International Conference (AAIC; 22–26 July, IL, USA), Jeff Williamson (Wake Forest School of Medicine, NC, USA) announced results from the SPRINT MIND study. For the first time, the trial demonstrated significant reductions in the risk of mild cognitive impairment (MCI) and the combination of MCI and dementia through aggressive lowering of systolic blood pressure.
The results of this large-scale, long-term clinical trial provide the strongest evidence to date about reducing risk of MCI and dementia through the treatment of high blood pressure.
Restricted Content / Members Only